Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2011 1
2015 2
2016 2
2017 4
2018 2
2019 2
2020 3
2021 2
2022 1
2023 4
2024 4
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
What grades and achievement tests measure.
Borghans L, Golsteyn BH, Heckman JJ, Humphries JE. Borghans L, et al. Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13354-13359. doi: 10.1073/pnas.1601135113. Epub 2016 Nov 8. Proc Natl Acad Sci U S A. 2016. PMID: 27830648 Free PMC article.
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson's Disease.
Eijsvogel PPNM, Borghans LGJM, Prins S, Moss L, van Kraaij SJW, van Brummelen E, Klaassen E, Martin RS, Bautista E, Ford AP, Kremer PHC, Groeneveld GJ, Vargas GA. Eijsvogel PPNM, et al. Among authors: borghans lgjm. J Parkinsons Dis. 2024;14(6):1149-1161. doi: 10.3233/JPD-240039. J Parkinsons Dis. 2024. PMID: 39213090 Free PMC article. Clinical Trial.
Does Expert Advice Improve Educational Choice?
Borghans L, Golsteyn BH, Stenberg A. Borghans L, et al. PLoS One. 2015 Dec 21;10(12):e0145378. doi: 10.1371/journal.pone.0145378. eCollection 2015. PLoS One. 2015. PMID: 26692388 Free PMC article.
First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.
van Kraaij SJW, Gal P, Borghans LGJM, Klaassen ES, Dijkstra F, Winrow C, Glasser C, Groeneveld GJ. van Kraaij SJW, et al. Among authors: borghans lgjm. Clin Transl Sci. 2023 Aug;16(8):1381-1395. doi: 10.1111/cts.13537. Epub 2023 May 3. Clin Transl Sci. 2023. PMID: 37118895 Free PMC article. Clinical Trial.
Randomized placebo-controlled crossover study to assess tolerability and pharmacodynamics of zagociguat, a soluble guanylyl cyclase stimulator, in healthy elderly.
van Kraaij SJW, Borghans L, Klaassen ES, Gal P, van der Grond J, Tripp K, Winrow C, Glasser C, Groeneveld GJ. van Kraaij SJW, et al. Among authors: borghans l. Br J Clin Pharmacol. 2023 Dec;89(12):3606-3617. doi: 10.1111/bcp.15861. Epub 2023 Aug 13. Br J Clin Pharmacol. 2023. PMID: 37488930 Free article. Clinical Trial.
30 results